Insider plans sale of 87,010 ordinary shares

An insider has filed a notice of proposed sale under Rule 144 to sell 87,010 ordinary shares through Oppenheimer & Co. Inc. on or about 02/02/2026, with the shares listed on Nasdaq.

Rhea-AI Filing Summary

An insider has filed a notice of proposed sale under Rule 144 to sell 87,010 ordinary shares through Oppenheimer & Co. Inc. on or about 02/02/2026, with the shares listed on Nasdaq. The aggregate market value of this planned sale is stated as 603,849.40, based on the figures in the notice.

The insider, identified as Gat Amnon, previously sold ordinary shares of the same issuer during the past three months. These earlier sales were 16,000 shares on 11/03/2025 for 62,404.91, 33,351 shares on 12/01/2025 for 148,918.59, and 90,559 shares on 01/02/2026 for 549,741.24. The shares to be sold were originally acquired on 02/21/2017 through an employee stock option plan, with cash payment upon exercise.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for DRTS disclose about upcoming share sales?

The filing discloses a planned sale of 87,010 ordinary shares on or about 02/02/2026 through Oppenheimer & Co. Inc. on Nasdaq. It also lists recent sales over the prior three months, detailing share counts and gross proceeds for each transaction.

How many DRTS shares has the insider recently sold under Rule 144?

The insider sold 16,000 ordinary shares on 11/03/2025, 33,351 shares on 12/01/2025, and 90,559 shares on 01/02/2026. These transactions generated gross proceeds of 62,404.91, 148,918.59, and 549,741.24, respectively, according to the notice.

At what market value is the proposed 87,010-share DRTS sale priced in the notice?

The proposed sale of 87,010 ordinary shares is shown with an aggregate market value of 603,849.40. This figure represents the total value for the planned transaction as reported, rather than a guarantee of actual proceeds from the future sale.

How and when were the DRTS shares being sold originally acquired by the insider?

The shares were acquired on 02/21/2017 through an employee stock options plan from the issuer. The notice states that 87,010 shares were obtained, with the nature of payment described as cash upon exercise in connection with exercising those options.

Which broker and exchange are listed for the planned DRTS share sale?

The planned sale of 87,010 ordinary shares is to be executed through Oppenheimer & Co. Inc., located in New York. The notice names Nasdaq as the securities exchange where these ordinary shares are listed for trading in connection with the transaction.

Who is the selling security holder in the DRTS Form 144 filing and what is their role?

The selling security holder identified is Gat Amnon, listed with an address in Kiryat Hamada. The filing describes prior and planned sales of ordinary shares for this person’s account under Rule 144, but does not specify a formal corporate title or position in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/02/2026 - 08:27 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001968258
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Alpha Tau Medical Ltd.
SEC File Number	001-41316
Address of Issuer	KIRYAT HAMADA 5 JERUSALEM ISRAEL 9777605
Phone	972-3-577-4115
Name of Person for Whose Account the Securities are To Be Sold	Gat Amnon
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co Inc. Broad 85 St. New York NY 10004	87010	603849.40	70380570	02/02/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	02/21/2017	Employee Stock Options plan	Issuer			87010	02/02/2026	Cash Upon Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Gat Amnon KIRYAT HAMADA 5 JERUSALEM L3 9777605	Ordinary	11/03/2025	16000	62404.91
Gat Amnon KIRYAT HAMADA 5 JERUSALEM L3 9777605	Ordinary	12/01/2025	33351	148918.59
Gat Amnon KIRYAT HAMADA 5 JERUSALEM L3 9777605	Ordinary	01/02/2026	90559	549741.24

144: Remarks and Signature

Remarks	Under 10b5 sale plan signed on 03-24-25
Date of Notice	02/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/24/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Amnon Gat
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)